Literature DB >> 3191308

Psychological effects of dieting.

C Warren1, P J Cooper.   

Abstract

Seven men and seven women, all of normal weight, were assessed by means of daily visual analogue scales for a two-week baseline period and for two weeks during which they were placed on a calorie-restricted diet. There were no significant changes in mood and no sex differences. Compared with the baseline, during the diet there were significant changes in their cognitions concerning eating: subjects were more preoccupied with thoughts about food, had strong urges to eat more frequently and were more likely to feel out of control of their eating.

Entities:  

Mesh:

Year:  1988        PMID: 3191308     DOI: 10.1111/j.2044-8260.1988.tb00787.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  5 in total

1.  Lorcaserin--not a new weapon in the battle with appetite.

Authors:  Jason C G Halford
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

2.  Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  B A Reeder; A Angel; M Ledoux; S W Rabkin; T K Young; L E Sweet
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

Review 3.  Pharmacological management of appetite expression in obesity.

Authors:  Jason C G Halford; Emma J Boyland; John E Blundell; Tim C Kirkham; Joanne A Harrold
Journal:  Nat Rev Endocrinol       Date:  2010-03-16       Impact factor: 43.330

Review 4.  Serotonergic anti-obesity agents: past experience and future prospects.

Authors:  Jason C G Halford; Emma J Boyland; Clare L Lawton; John E Blundell; Joanne A Harrold
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

Review 5.  Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data?

Authors:  Carl A Roberts; Paul Christiansen; Jason C G Halford
Journal:  Acta Diabetol       Date:  2017-04-19       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.